Murakami, S., Kawanaka, M., Imajo, K., Shiota, S., Miyake, N., Sue, M., Adachi, T., Takeuchi, Y., Onishi, H., Takaki, A., Urata, N., Kawamoto, H., Otsuka, M. (2026). CLEIA-based type IV collagen 7S for second-step assessment of MRE-defined clinically significant fibrosis in MASLD with indeterminate FIB-4. Scientific Reports. https://doi.org/10.1038/s41598-026-58113-w